American National Bank & Trust’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,000
Closed -$22.9K 649
2025
Q2
$22.9K Buy
+2,000
New +$22.5K ﹤0.01% 462
2021
Q2
Sell
-1,200
Closed -$33K 299
2021
Q1
$33K Hold
1,200
0.01% 163
2020
Q4
$30K Hold
1,200
0.01% 159
2020
Q3
$25K Hold
1,200
0.01% 162
2020
Q2
$18K Buy
+1,200
New +$15.2K 0.01% 169
2018
Q3
Sell
-500
Closed -$22K 197
2018
Q2
$22K Sell
500
-1,291
-72% -$64.2K 0.01% 189
2018
Q1
$87K Buy
+1,791
New +$89.5K 0.03% 136
2015
Q4
Sell
-7
Closed 233
2015
Q3
$0 Buy
+7
New +$73 ﹤0.01% 260

Other funds holding CC

American National Bank & Trust's CC Position: Q3 2025 in Review

American National Bank & Trust sold out of Chemours (CC) in Q3 2025, closing a stake of 2,000 shares — an estimated $22.9K sold.

American National Bank & Trust first reported a position in CC in Q3 2015 and held it in 8 quarters. The position peaked at $87K in Q1 2018. 428 funds tracked by Wall St. Rank hold CC as of Q3 2025.

  • American National Bank & Trust reported no remaining Chemours position as of Q3 2025 after selling out during the quarter.
  • American National Bank & Trust sold 2,000 Chemours shares in Q3 2025, an estimated $22.9K.
  • American National Bank & Trust first reported a position in Chemours in Q3 2015 and held it in 8 quarters.
  • American National Bank & Trust's Chemours position peaked at $87K in Q1 2018.
  • 428 funds tracked by Wall St. Rank held Chemours as of Q3 2025.

Based on American National Bank & Trust's 13F filing for Q3 2025, filed 21 Oct 2025.